Patient socioeconomic status as a prognostic factor for allo-SCT

Bone Marrow Transplantation

Volumn 43, Issue 7, 2009, Pages 571-577

  Silla, L ^a   Fischer, G B ^a   Paz, A ^a   Daudt, L E ^a   Mitto, I ^a   Katz, B ^a   da Graca Grossini M ^a   Bittencourt, H N ^a   Jochims, A ^a   Fogliatto, L ^a   Bittar, C M ^a   Friedrisch, J R ^a   Bittencourt, R I ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRAZIL; CANCER RADIOTHERAPY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SOCIAL STATUS; THROMBOCYTE;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SOCIAL CLASS;

EID: 64949159122     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.358     Document Type: Article

References (32)

1. Schmitz N, Gratwohl A, Goldman JM. Allogeneic and autologous transplantation for haematological diseases, solid tumors and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17: 471-477.
2. Nash R, Pepe M, Storb R, Longton G, Pettinger M, Anasetti C et al. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.
3. Winston D, Gale R, Meyer D, Young L. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979; 58: 1-31.
4. Bittencourt H, Rocha V, Chevret S, Socié G, Espérou H, Devergie A et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 99: 2726-2733.
5. Blakely T, Atkinson J, Kiro C, Blaiklock A, D'Souza A. Child mortality, socioeconomic position, and one-parent families: Independent association and variation by age and cause of death. Int J Epidemiol 2003; 32: 410-418.
6. Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ et al. Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE study. Behav Modif 2003; 27: 54-67.
7. Bassanesi S, Azambuja MI, Achutti A. Premature mortality due to cardiovascular disease and social inequalities in Porto Alegre: From evidence to action. Arq Bras Cardiol 2008; 90: 403-412.
8. Cesaroni G, Farchi S, Davoli M, Forastiere F, Perucci CA. Individual and area-based indicators of socioeconomic status in childhood asthma. Eur Respir J 2003; 22: 619-624.
9. Kapral M, Wang H, Mamdani M. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002; 33: 274-275.
10. Cross C, Harris J, Recht A. Race, socioeconomic status and breast carcinoma in the US: What have we learned from clinical studies. Cancer 2002; 95: 1988-1999.
11. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J. Inequalities in survival from colorectal cancer: A comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health 2003; 57: 301-309.
12. Hole D, McArdle C. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surgery 2002; 89: 586-590.
13. Butkus D, Dottes A, Meydrech EF, Barber WH. Effect of poverty and other socio-economic variables on renal allograft survival. Transplantation 2001; 72: 261-266.
14. Savage D, Lindenbaum J, Ryzin J, Struening E, Garret T. Race, poverty, and survival in multiple myeloma. Cancer 1984; 54: 3085-3094.
15. Viana MB, Murao M, Ramos G, Oliveira HM, Carvalho RI, Bastos M et al Malnutrition as a prognostic factor in lymphoblastic leukaemia: A multivariate analysis. Arch Dis Child 1994; 71: 304-310.
16. Viana MB, Fernandes RAF, Oliveira BMA, Murao M, Paes CA, Duarte AA. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica 2001; 86: 113-120.
17. Baker KS, Loberiza Jr FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol 2005; 23: 7032-7042.
18. Karanth M, Begum G, Cook M, Lawson S, Porter C, Lister N et al. Increased acute GvHD and higher transplant-related mortality in non-Caucasians undergoing standard sibling allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 419-423.
19. Daudt LE, Zechmaister D, Portal L, Neto EC, Silla LM, Giuliani R. Neonatal screeningfor hemoglobinopathies: A pilot study in Porto Alegre, Rio Grande do Sul, Brazil. Cad Saude Publica 2002; 18: 833-841.
20. http://www.ibge.gov.br/home/estatistica/populacao/contagem2007/ popmunic2007layoutTCU14112007.xls-visited in June 2008.
21. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
22. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
23. Alexanian R, Balcerzak S, Bonnet JD, Gehan EA, Haut A, Hewlett JS et al. Prognostic factors in multiple myeloma. Cancer 1975; 36 1192-1201.
24. Hu E, Hufford S Lukes R, Berstein-Singer M, Sobel G, Gill P, Pinter-Brown L et al. Third-world Hodgkin's disease at Los Angeles County - University of Southern California Medical Center. J Clin Oncol 1998; 6: 1285-1292.
25. Loureiro MM, Morais JC, Milito CB, Portugal RD, Pulcher W, Spector N. Expression of Epstein-Barr vírus in patients with Hodgkin's disease: report of 64 cases from Rio de Janeiro, Brazil. J Bras Patol Méd Lab 2004; 40: 37-40.
26. Spector N, Costa MA, Pulcheri W, Salgado RC, Nucci M, Andrade CA et al. C-MOPP/ABV yields good results in a public hospital population with Hodgkin's disease in Brazil. Cancer 1993; 71: 2823-2827.
27. Eid KAB, Miranda ECM, Vigorito AC, Aranha FJP, Oliveira GB, De Souza CA. The availability of full match sibling donors and feasibility of allogeneic bone marrow transplantation in Brazil. Braz J Med Biol Res 2003; 36: 315-321.
28. Horowitz MM, Rowlings PA. An update from the International Bone Marrow Transplantation Registry and the autologous blood and marrow transplant registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997; 4: 395-400.
29. Loberiza Jr FR, Zhang M-J, Lee SJ, Klein JP, LeMaistre CF, Serna DS et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood 2005; 105: 2979-2987.
30. Lisot CL, Silla LM. Screening for hemoglobinopathies in blood donors from Caxias do Sul, Brazil: Prevalence in an Italian colony. Cad Saude Publica 2004; 20: 1595-1601.
31. Sommer CK, Goldberck AS, Wagner SC, Castro SM. Neonatal screening for hemoglobinopathies: A one year experience in the public health system in Rio Grande do Sul, Brazil. Cad Saude Publica 2006; 22: 1709-1714.
32. http://pt.wikipedia.org/wiki/Rio_Grande_do_Sul-visited in June 2008.